VIRUS REPLICATION AT THE INTERCELLULAR LEVEL |
P 1 |
Modeling the intracellular dynamics of the influenza A infection
M. Schelker, M. Flöttmann, C. Sieben, A. Herrmann, E. Klipp, Humboldt-Universität zu Berlin/D |
MODELS OF SIMPLE IN VITRO VIRAL INFECTION SYSTEMS |
P 2 |
Improving cell based models through viral vector technology - Chances for target research and screening approaches
M. Salomon, V. Jagusch, S. Schrödel, C. Thirion, SIRION BIOTECH GmbH, Martinsried/D |
P 3 |
Population balance modeling of influenza virus replication during vaccine production - Parameter estimation and numerical methods
R. Dürr, Max Planck Institute for Dynamics of Complex Technical Systems; T. Müller, Otto-von-Guericke University Magdeburg/D; A. Kienle, Otto-von-Guericke University Magdeburg and Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg/Germany |
IN VIVO MODELING AND HOW TO IMPLEMENT THE IMMUNE RESPONSE |
P 4 |
Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response
M. Rinas, German Cancer Research Center (DKFZ), Heidelberg/D; U. Rand, J. Schwerk, G. Nöhren, M. Linnes, A. Kröger, Helmholtz Centre for Infection Research (HZI), Braunschweig/D; M. Flossdorf, K. Kály-Kullai, German Cancer Research Center (DKFZ), Heidelberg/D; H. Hauser, Helmholtz Centre for Infection Research (HZI), Braunschweig/D; T. Höfer, German Cancer Research Center (DKFZ), Heidelberg/D; M. Köster, Helmholtz Centre for Infection Research (HZI), Braunschweig/D |
P 5 |
PK-PD modeling of interferon-free treatment with Sofosbuvir and Ribavirin in patients with chronic hepatitis C
D. Bon, E. Herrmann, Goethe University Frankfurt/D; B. Shivakumar, Y.-J. Lee, L. Heytens, M. Polis, NIAID, Bethesda, MD/USA; H. Masur, CCMD/CC/NIH, Bethesda, MD/USA; W.T. Symonds, J. McHutchison, Gilead Sciences, Inc., Foster City, CA/USA; S. Kottilil, A. Osinusi, NIAID, Bethesda, MD/USA |
P 6 |
Selective interference and CTL escape
V. Garcia, R. Regoes, ETH Zurich/CH |
P 7 |
Dynamics of hepatitis B surface antigen after liver transplantation
N. Filmann, Goethe University Frankfurt/D; J. Rosenau, University of Kentucky, Lexington, KY/USA; M.P. Manns, H. Wedemeyer, Hannover Medical School/D; E. Herrmann, Goethe University Frankfurt/D |
P 8 |
Stochastic migration and signal integration facilitate rapid and robust T-cell recruitment
J. Textor, Utrecht University/NL; S.E. Henrickson, U.H. von Andrian, Harvard University, Boston, MA/USA; J. Westermann, Universität Lübeck/D; R.J. de Boer, Utrecht University/NL; J.B. Beltman, Dutch Cancer Institute, Amsterdam/NL
|
P 9 |
Quantification of virus infection dynamics during acute phase in HIV-1 and Vpu ΔHIV-1 infected humanized mice
H. Ikeda, Kyushu University, Fukuoka/J; R. de Boer, Utrecht University/NL; Y. Koizumi, Kanazawa University/J; K. Sato, Y. Koyanagi, Kyoto University/J; S. Iwami, Kyushu University, Fukuoka/J |